Flo Health Raises $200M for Fertility Tracking

Flo Health is breaking ceilings.

Bullish. The fertility-tracking app secured over $200M from General Atlantic in a Series C, surpassing a $1B valuation.

With ~5M premium and 70M free users, London-based Flo is the world’s number-two health and fitness app by revenue — with gross bookings expected to increase >50% YoY in 2024.

Expanding its core, the company will use funds to push into menopause and sexual wellness.

Stacking up. Women of menstruating age comprise one-quarter of the global population, and healthtech is finally valuing their needs.

• FDA-cleared birth control app Natural Cycles closed a $55M Series C in May.
• German cycle-tracking app Clue added €7M in April 2023 and crowdfunded >€1M more.
• Syncing with top apps, Oura is prioritizing women with new reproductive health insights.

Still, some worry about privacy risks post-Roe. Of note, both Flo and competitor Glow have faced backlash for security breaches.

In response, Flo developed “Anonymous Mode,” eliminating need for personal info altogether.

Takeaway: Women’s health is officially proven as a profitable market. Vying for women’s wallets, the onus is now on startups to earn trust and prove more than an opportune cash grab.